F.D.A. Approves New H.I.V.-Prevention Drug, but Not for Women

Citing a lack of evidence, the agency will require Gilead to conduct further trials in women.


Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>